Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pale sulfonated shale oil (PSSO) is a naturally derived substance obtained from the distillation of oil-rich sedimentary rocks (shale), followed by sulfonation and neutralization. Unlike dark sulfonated shale oil, PSSO is highly purified to remove dark-colored and odorous components, making it more suitable for cosmetic and dermatological applications. It exhibits anti-inflammatory, anti-pruritic, and anti-microbial properties. It is primarily used in the treatment of inflammatory skin conditions such as atopic eczema, psoriasis, and seborrheic dermatitis. Clinical studies have demonstrated its efficacy in reducing symptoms of mild to moderate atopic eczema in children, serving as a well-tolerated alternative to topical corticosteroids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pale sulfonated shale oil.